Cambridge Trust’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | $13M | Hold |
100,857
| – | – | 0.49% | 64 |
|
2023
Q4 | $10.4M | Buy |
100,857
+525
| +0.5% | +$54.3K | 0.43% | 67 |
|
2023
Q3 | $9.12M | Sell |
100,332
-9,914
| -9% | -$902K | 0.42% | 67 |
|
2023
Q2 | $8.92M | Hold |
110,246
| – | – | 0.4% | 65 |
|
2023
Q1 | $8.77M | Hold |
110,246
| – | – | 0.42% | 62 |
|
2022
Q4 | $7.46M | Hold |
110,246
| – | – | 0.33% | 71 |
|
2022
Q3 | $5.49M | Sell |
110,246
-2,200
| -2% | -$110K | 0.26% | 82 |
|
2022
Q2 | $6.26M | Sell |
112,446
-886
| -0.8% | -$49.4K | 0.27% | 82 |
|
2022
Q1 | $6.29M | Sell |
113,332
-146
| -0.1% | -$8.11K | 0.22% | 91 |
|
2021
Q4 | $6.35M | Buy |
+113,478
| New | +$6.35M | 0.2% | 94 |
|
2016
Q4 | – | Sell |
-12,072
| Closed | -$251K | – | 269 |
|
2016
Q3 | $251K | Sell |
12,072
-186
| -2% | -$3.87K | 0.02% | 229 |
|
2016
Q2 | $330K | Buy |
+12,258
| New | +$330K | 0.03% | 201 |
|